New technologies are emerging for clinical laboratories to address challenges faced within clinical diagnostics today. Liquid chromatography mass spectrometry (LC/MS) is an emerging technology becoming widely adopted to overcome challenges faced by clinical scientists worldwide.

1. Emerging technologies for clinical laboratories
Is your lab prepared for
a new era of healthcare?
What are the top three challenges
frequently faced by clinical
laboratory scientists?
Ensuring
laboratory
compliance
2
Maintaining
acceptable
turnaround times
3
Providing
high quality
results
1
Shorter,
less manual
prep time
Where does industry anticipate the
most significant changes?
LC/MS in the clinical laboratory
Working with
suppliers
providing
services
& support
Working with
manufacturers
who provide cost
effective analysis
on staffing,
instrument costs
& time savings
LC/MS in the
clinical laboratory
Next generation sequencing/
personalized medicine
Molecular diagnostics
at point of care
Multiplexing molecular
diagnostics
81%of those working in clinical
laboratories worldwide are
familiar with mass
spectrometry
19%
I AM NOT
FAMILIAR
16%
I AM AN
EXPERT
27%
I FULLY
UNDERSTAND
43%
I UNDERSTAND
BASIC CONCEPT
What solutions were identified by
clinical scientists to address these
challenges?
How familiar are you
with clinical mass
spectrometry?
Research commissioned by Thermo Fisher Scientific
working with SelectScience®
worldwide
clinical diagnostic audience
More than 1 in 2 clinical
scientists are looking
to invest in LC/MS
within the next
10 years
The top three benefits scientists would like to have when
investing in LC/MS for the clinical laboratory are:
Regulatory
compliance
Traceability Quality of
results
1 in 3 of those is
looking to invest within
the next one to
two years
© 2016 Thermo Fisher Scientific Inc. All rights reserved.
http://www.thermofisher.com